Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-27

Clinical Trial Update: IVIG in Painful Sensory Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for IVIG in sensory neuropathy, including small fiber neuropathy; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Sorlandet Hospital HF | Conditions: Sensory Neuropathy, Small Fiber Neuropathy | Phase 4 | Status: NOT_YET_RECRUITING